Skip to content

The Lean Meats Mediterranean Diet Study

Effects of Incorporating Red Meat Into a Mediterranean-style Dietary Pattern on Cardiometabolic and Emotional Well-being

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02573129
Enrollment
41
Registered
2015-10-09
Start date
2015-05-31
Completion date
2017-06-30
Last updated
2018-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Dietary Modification

Keywords

cardiovascular disease risk, Mediterranean diet, red meat

Brief summary

The purpose of the proposed research study is to assess the effects of including greater amounts of minimally processed red meat (lean pork and beef) into a Mediterranean Diet on cardiometabolic and emotional well-being.

Detailed description

All subjects will complete an 18-wk randomized crossover study. Following a 2-wk baseline testing period to assess cardiometabolic and emotional well-being and habitual diet, subjects will consume a Mediterranean-style, weight-maintenance diet that is either restricted or rich in lean, minimally processed red meat for 5 weeks. Following a 4-wk washout period and second 2-wk baseline testing, subjects will consume the Mediterranean Diet with the alternate predominant animal protein sources for 5 weeks. Cardiometabolic and emotional well-being will be assessed during baseline and post periods.

Interventions

OTHERRed Meat Restricted

restrict intake of red meat while a Mediterranean diet

OTHERRed Meat Rich

Mediterranean diet rich in red meat

Sponsors

National Pork Board
CollaboratorOTHER
National Cattlemen's Beef Association, a contractor to the Beef Checkoff
CollaboratorINDUSTRY
Purdue University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female 30-69 years old * BMI 25-37 kg/m2 * Total cholesterol \<240 mg/dL * Low-density lipoprotein \<160 mg/dL * Triglycerides \<400 mg/dL * Fasting glucose \<110 mg/dL * Systolic blood pressure \<160 mmHg * Diastolic blood pressure \<100 mmHg * Body weight \<300 lb * Weight stable for 3 months prior (±10 lb) * Stable physical activity regimen 3 months prior ≤3 h/wk of moderate or high intensity exercise resistance or aerobic training * Medication use stable for 6 months prior.

Exclusion criteria

* Diabetic * Smoker

Design outcomes

Primary

MeasureTime frameDescription
blood pressure5 weeksclinical and 24-hr monitoring
lipid profile5 weekscholesterol panel

Secondary

MeasureTime frameDescription
sleep quality5 weekssleep assessed by using actigraphy / actiwatch
sleep assessment5 wksSleep assessed by questionnaires using the Pittsburgh Sleep Quality Index
assessment of sleep5 weeksSleep assessed by questionnaires using the SF-36v2® Health Survey
emotional well-being5 weeksquality of life questionnaires

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026